InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Giacobello Scott M., 首席财务官. Insider active across 3 companies, notably GW Pharmaceuticals PLC. Cumulatively, 7 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €748k. Activity tracked since 26 September 2022. The latest transaction was filed on 16 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Giacobello Scott M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
77,000 股@ US$3.8633.6% 占其流量Common StockSEC:0001754154-26-000010:0
141,600 股@ US$4.1366.4% 占其流量Common StockSEC:0001754154-26-000010:1
473,902 股Common StockSEC:0001754154-26-000005:0
6,750 股Common StockSEC:0001754154-26-000002:0
6,750 股Common StockSEC:0001415889-25-006318:0
20,000 股@ US$12.50100.0% 占其流量Common StockSEC:0001209191-22-051388:0
165,108 股Ordinary SharesSEC:0000899243-21-018661:0
7 条申报中的 7 条
About Giacobello Scott M.
Scott M. Giacobello is the Chief Financial Officer at GW Pharmaceuticals PLC. In this role, he is responsible for financial management and strategy of the company, which specializes in drug development. Scott plays a key role in financial planning and compliance, thereby contributing to the growth of the firm.
